Sonendo, Inc. (SONX)

USD 2.19

(6.31%)

Gross Profit Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual gross profit in 2023 was 10.72 Million USD , up 2.31% from previous year.
  • Sonendo, Inc.'s latest quarterly gross profit in 2024 Q2 was 3.13 Million USD , up 55.72% from previous quarter.
  • Sonendo, Inc. reported a annual gross profit of 10.48 Million USD in annual gross profit 2022, up 25.72% from previous year.
  • Sonendo, Inc. reported a annual gross profit of 8.33 Million USD in annual gross profit 2021, up 114.57% from previous year.
  • Sonendo, Inc. reported a quarterly gross profit of 3.13 Million USD for 2024 Q2, up 55.72% from previous quarter.
  • Sonendo, Inc. reported a quarterly gross profit of 3.34 Million USD for 2023 Q1, up 0.48% from previous quarter.

Annual Gross Profit Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Gross Profit of Sonendo, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 10.72 Million USD 2.31%
2022 10.48 Million USD 25.72%
2021 8.33 Million USD 114.57%
2020 3.88 Million USD -57.16%
2019 9.06 Million USD 0.0%

Peer Gross Profit Comparison of Sonendo, Inc.

Name Gross Profit Gross Profit Difference
Abbott Laboratories 22.13 Billion USD 99.952%
Allurion Technologies Inc. 41.49 Million USD 74.162%
Artivion, Inc. 229.17 Million USD 95.321%
Avanos Medical, Inc. 379.7 Million USD 97.176%
Butterfly Network, Inc. 16.85 Million USD 36.391%
Butterfly Network, Inc. 16.85 Million USD 36.391%
Bio-Rad Laboratories, Inc. 1.43 Billion USD 99.251%
Boston Scientific Corporation 9.89 Billion USD 99.892%
Perspective Therapeutics, Inc. 1.63 Million USD -556.181%
CONMED Corporation 643.06 Million USD 98.333%
Edwards Lifesciences Corporation 4.62 Billion USD 99.768%
Paragon 28, Inc. 172.79 Million USD 93.795%
Glaukos Corporation 239.13 Million USD 95.516%
Globus Medical, Inc. 1.02 Billion USD 98.949%
Inspire Medical Systems, Inc. 528.22 Million USD 97.97%
Integer Holdings Corporation 418.28 Million USD 97.437%
Medtronic plc 19.45 Billion USD 99.945%
Nevro Corp. 290.06 Million USD 96.304%
Owlet, Inc. 22.58 Million USD 52.53%
Penumbra, Inc. 682.64 Million USD 98.429%
Vicarious Surgical Inc. -1.85 Million USD 678.317%
Smith & Nephew plc 3.7 Billion USD 99.71%
STERIS plc 2.23 Billion USD 99.52%
Stryker Corporation 13.05 Billion USD 99.918%
Vapotherm, Inc. 28.28 Million USD 62.09%
Zimmer Biomet Holdings, Inc. 5.31 Billion USD 99.798%